(XSMI) Xtrackers Switzerland 1D - Ratings and Ratios
Swiss, Equities
Description: XSMI Xtrackers Switzerland 1D
The Xtrackers Switzerland UCITS ETF 1D (SW:XSMI) is an exchange-traded fund that tracks the Morningstar Switzerland TME NR CHF Index, providing investors with exposure to the Swiss equity market. As a Switzerland Equity ETF, it is designed to capture the performance of the Swiss market, which is known for its stability and dominance in the pharmaceutical and financial sectors.
From a technical analysis perspective, the ETF is currently trading at CHF 126.46, slightly below its 20-day Simple Moving Average (SMA) of CHF 127.88, indicating a potential short-term bearish trend. However, it is above its 50-day SMA of CHF 124.89 and 200-day SMA of CHF 124.63, suggesting a longer-term bullish outlook. The Average True Range (ATR) of 1.20, or 0.95% of the current price, indicates moderate volatility. Given the current price action and technical indicators, a potential trading range between CHF 124.63 and CHF 134.20 can be expected.
With Assets Under Management (AUM) of CHF 1360.89 million, the Xtrackers Switzerland UCITS ETF 1D is a sizable fund, indicating a good level of liquidity and investor interest. This, combined with its tracking of a reputable index like the Morningstar Switzerland TME NR CHF, makes it a viable option for investors seeking exposure to the Swiss market.
Forecasting the future performance of XSMI involves analyzing both its technical and fundamental data. Given the current technical indicators and the fundamental strength of the Swiss market, it is plausible that XSMI could continue its upward trajectory, potentially reaching new 52-week highs. However, if the broader market experiences a downturn, XSMI could retreat to its 200-day SMA at CHF 124.63. A key level to watch is the 52-week high of CHF 134.20; a break above this could signal further upside potential.
Investors should monitor the ETFs price action relative to its SMAs and the overall market conditions. A sustained move above the 20-day SMA could be a bullish signal, while a drop below the 200-day SMA might indicate a more significant downturn. As with any investment, its crucial to consider both the potential for growth and the risks associated with market volatility.
Additional Sources for XSMI ETF
XSMI ETF Overview
Market Cap in USD | 1,675m |
Category | Switzerland Equity |
TER | 0.31% |
IPO / Inception | 2007-01-22 |
XSMI ETF Ratings
Growth Rating | 33.5 |
Fundamental | - |
Dividend Rating | 54.3 |
Rel. Strength | -12.5 |
Analysts | - |
Fair Price Momentum | 115.53 CHF |
Fair Price DCF | - |
XSMI Dividends
Dividend Yield 12m | 1.57% |
Yield on Cost 5y | 1.89% |
Annual Growth 5y | 7.54% |
Payout Consistency | 89.0% |
Payout Ratio | % |
XSMI Growth Ratios
Growth Correlation 3m | 12% |
Growth Correlation 12m | 33.2% |
Growth Correlation 5y | 57.8% |
CAGR 5y | 3.81% |
CAGR/Max DD 5y | 0.18 |
Sharpe Ratio 12m | 1.15 |
Alpha | -9.40 |
Beta | 0.504 |
Volatility | 9.94% |
Current Volume | 4.9k |
Average Volume 20d | 7k |
Stop Loss | 120.8 (-3%) |
As of July 16, 2025, the stock is trading at CHF 124.54 with a total of 4,877 shares traded.
Over the past week, the price has changed by -0.80%, over one month by -1.56%, over three months by +3.83% and over the past year by -1.29%.
Neither. Based on ValueRay´s Analyses, Xtrackers Switzerland 1D is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 33.53 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XSMI is around 115.53 CHF . This means that XSMI is currently overvalued and has a potential downside of -7.23%.
Xtrackers Switzerland 1D has no consensus analysts rating.
According to our own proprietary Forecast Model, XSMI Xtrackers Switzerland 1D will be worth about 128.7 in July 2026. The stock is currently trading at 124.54. This means that the stock has a potential upside of +3.36%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 128.7 | 3.4% |